Showing results (2471-2480 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|April 15, 2014
Treatment of advanced breast cancer with chinese medicinal herbs of Fei decoction: a case reportG M Lv, M Hu, R Z Chen, et al.Current Pharmaceutical Biotechnology|April 15, 2014
In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted single-walled carbon nanotubes systemHuijuan Zhang, Lin Hou, Xiaojing Jiao, et al.Current Pharmaceutical Biotechnology|April 15, 2014
The current status of novel PET radio-pharmaceuticals in radiotherapy treatment planning of gliomaGiulia Marvaso, Agnese Barone, Nicola Amodio, et al.Current Pharmaceutical Biotechnology|January 25, 2017
Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical PracticeJerome Chatelin, Maria G Stathopoulou, Alex-Ander A Arguinano, et al.Current Pharmaceutical Biotechnology|January 4, 2017
Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical PracticeErika Cecchin, Rossana Roncato, Hendrik J Guchelaar, et al.Current Pharmaceutical Biotechnology|December 31, 2016
The Effect of Pullulan on the Growth and Acidifying Activity of Selected Stool Microflora of HumanAnna Chlebowska-Smigiel, Małgorzata Gniewosz, Marek Kieliszek, et al.Current Pharmaceutical Biotechnology|October 25, 2016
Evaluation of Antioxidant Activity of Phytol Using Non- and Pre-Clinical ModelsJéssica P Costa, Md T Islam, Pauline S Santos, et al.Current Pharmaceutical Biotechnology|May 9, 2014
Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future researchStanislaw P Stawicki, Thomas J PapadimosCurrent Pharmaceutical Biotechnology|May 9, 2014
Amniotic fluid embolism: what level of scientific evidence can be drawn? A systematic reviewPaola Frati, Zeno Foldes-Papp, Simona Zaami, et al.Current Pharmaceutical Biotechnology|November 16, 2016
IgG Fc Fragment as a Scaffold for Development of Targeted TherapeuticsGordana W Knopp, Gerhard Stadlmayr, Florian RukerPageof 303